Patent · US Active

Sesquiterpenoids

US9670226B2 · kind B2 · utility

0Cited by

0References

17Claims

0Family size

Assignee

National Institute of Biological Sciences, Beijing · CN

Inventors

Xiaoguang Lei · Yongchang Subdistrict, CN
Sudan He · Beijing, CN
Chao Li · Beijing, CN
Ting Dong · Beijing, CN

Key dates

Filing date	Oct 24, 2016
Grant date	Jun 6, 2017
Priority date	—
Expiry date	Oct 24, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D493/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides novel compounds and compositions for inhibiting IKKα/β, including treating disorders associated with IKKα/β activity, including cancer, autoimmune and inflammatory disorders, with a compound of structure:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.